Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRA-216 in Moderate to Severe Atopic Dermatitis
NCT07810777Phase 2Recruiting
- Sponsor
- Prana Therapies
- Start
- Sep 2026
- Primary completion
- Sep 2027
- Countries
- 2
01
Overview
A Phase 2 trial of PRA-216 in atopic dermatitis (AD), sponsored by Prana Therapies. Started Sep 2026; status: recruiting.
02
Drugs
PRA-216
03
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on NCT07810777.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07810777.